183 related articles for article (PubMed ID: 12145174)
21. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes.
Kang ES; Park SY; Kim HJ; Kim CS; Ahn CW; Cha BS; Lim SK; Nam CM; Lee HC
Clin Pharmacol Ther; 2005 Aug; 78(2):202-8. PubMed ID: 16084854
[TBL] [Abstract][Full Text] [Related]
22. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.
Stumvoll M; Häring H
Diabetes; 2002 Aug; 51(8):2341-7. PubMed ID: 12145143
[TBL] [Abstract][Full Text] [Related]
23. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study.
Salopuro T; Pulkkinen L; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M;
Int J Obes (Lond); 2005 Oct; 29(10):1245-51. PubMed ID: 15997246
[TBL] [Abstract][Full Text] [Related]
24. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
Wang C; Zhai F; Chi Y; Wang G
Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802
[TBL] [Abstract][Full Text] [Related]
25. Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects.
Lindi V; Sivenius K; Niskanen L; Laakso M; Uusitupa MI
Diabetologia; 2001 Jul; 44(7):925-6. PubMed ID: 11508283
[No Abstract] [Full Text] [Related]
26. [Influence of polymorphism pro12Ala of PPARgamma gene on endothelium destruction in patients with diabetes mellitus t. 2].
Gacka M; Dobosz T; Szymaniec S; Bednarska-Chabowska D; Adamiec R
Pol Arch Med Wewn; 2005 Nov; 114(5):1055-65. PubMed ID: 16789503
[TBL] [Abstract][Full Text] [Related]
27. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514
[TBL] [Abstract][Full Text] [Related]
28. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Franks PW; Jablonski KA; Delahanty L; Hanson RL; Kahn SE; Altshuler D; Knowler WC; Florez JC;
Diabetologia; 2007 Dec; 50(12):2451-60. PubMed ID: 17898990
[TBL] [Abstract][Full Text] [Related]
29. Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study.
Siitonen N; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M
Diabetologia; 2004 Aug; 47(8):1416-24. PubMed ID: 15309292
[TBL] [Abstract][Full Text] [Related]
30. Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis.
Temelkova-Kurktschiev T; Hanefeld M; Chinetti G; Zawadzki C; Haulon S; Kubaszek A; Koehler C; Leonhardt W; Staels B; Laakso M
J Clin Endocrinol Metab; 2004 Sep; 89(9):4238-42. PubMed ID: 15356014
[TBL] [Abstract][Full Text] [Related]
31. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY
J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069
[TBL] [Abstract][Full Text] [Related]
32. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
Kubaszek A; Pihlajamäki J; Komarovski V; Lindi V; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
Diabetes; 2003 Jul; 52(7):1872-6. PubMed ID: 12829659
[TBL] [Abstract][Full Text] [Related]
33. The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese.
Iwata E; Yamamoto I; Motomura T; Tsubakimori S; Nohnen S; Ohmoto M; Igarashi T; Azuma J
Diabetes Res Clin Pract; 2003 Oct; 62(1):55-9. PubMed ID: 14581158
[TBL] [Abstract][Full Text] [Related]
34. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
Wang J; Kuusisto J; Vänttinen M; Kuulasmaa T; Lindström J; Tuomilehto J; Uusitupa M; Laakso M
Diabetologia; 2007 Jun; 50(6):1192-200. PubMed ID: 17437080
[TBL] [Abstract][Full Text] [Related]
35. Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator--activated receptor-gamma2 gene.
Stefan N; Fritsche A; Häring H; Stumvoll M
Diabetes; 2001 May; 50(5):1143-8. PubMed ID: 11334419
[TBL] [Abstract][Full Text] [Related]
36. The Pro12Ala polymorphism of the PPARgamma2 gene is associated with hepatic glucose uptake during hyperinsulinemia in subjects with type 2 diabetes mellitus.
Honka MJ; Vänttinen M; Iozzo P; Virtanen KA; Lautamäki R; Hällsten K; Borra RJ; Takala T; Viljanen AP; Kemppainen J; Pihlajamäki J; Knuuti J; Nuutila P; Laakso M
Metabolism; 2009 Apr; 58(4):541-6. PubMed ID: 19303976
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes.
Memisoglu A; Hu FB; Hankinson SE; Liu S; Meigs JB; Altshuler DM; Hunter DJ; Manson JE
Diabetes Care; 2003 Oct; 26(10):2915-7. PubMed ID: 14514601
[TBL] [Abstract][Full Text] [Related]
38. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.
Kilpeläinen TO; Lakka TA; Laaksonen DE; Mager U; Salopuro T; Kubaszek A; Todorova B; Laukkanen O; Lindström J; Eriksson JG; Hämäläinen H; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M;
Metabolism; 2008 Mar; 57(3):428-36. PubMed ID: 18249219
[TBL] [Abstract][Full Text] [Related]
39. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
[TBL] [Abstract][Full Text] [Related]
40. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients.
Zietz B; Barth N; Spiegel D; Schmitz G; Schölmerich J; Schäffler A
Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):60-6. PubMed ID: 11928067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
